APOE and Cognitive impairment: Both objective (e.g., actigraphy) and subjective sleep measures predicted cognitive impairment, while cerebrospinal fluid (CSF) biomarkers and apolipoprotein E epsilon 4 (APOE ε4) genotype moderated these associations.